The Biomimetic MicroEngineering (BioME) laboratory has focused on innovating bioinspired engineering principles to uncover the fundamental mechanism in human health and diseases. The human Organ-on-a-Chip, also known as the Microphysiological System (MPS), has emerged as an alternative experimental model to accurately recapitulate the host-microbiome ecosystem and predict human physiological responses. We have created novel biomimicry to reconstitute the three-dimensional (3D) physical structure, physiological functions, and dynamic biomechanics of the living human gut.
We are particularly interested in emulating the host-microbiome interactions that orchestrate intestinal homeostasis and disease development. In collaboration with clinicians, our breakthrough technology enables us to develop unprecedented “Personalized Disease-on-a-Chip” models by integrating patient-derived organoids, microbiomes, and immune cells. Using this model, we have delved into the pathological contribution of the gut microbiome in gastrointestinal diseases such as inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), colorectal cancer (CRC), and infectious diseases.
Our overarching goal is to understand causality vs. consequence of the host-microbiome crosstalk at various disease milieus by leveraging a patient-specific Disease-on-a-Chip. We will continually innovate our disruptive technology to manipulate pathophysiological manifestation in the human oral cavity, nasal path, vagina, placenta, skin, liver, and gut-brain axis. Finally, we will disseminate our cutting-edge technology to contribute to scientific, clinical, and pharmaceutical communities by unraveling high-risk medical problems.
Hyun Jung Kim, PhD, is the Principal Investigator of The Biomimetic Microengineering (BioME) Laboratory in the Department of Inflammation and Immunity at Cleveland Clinic. He has focused on innovating microphysiological platform technologies to uncover fundamental questions in human health and diseases. By leveraging the miniaturized human “Gut-on-a-chip” microsystem, Dr. Kim has developed paradigm-shifting models that reconstitute the physical structure, physiological function, and mechanical dynamics of the living human intestine (Nat. Protoc. 2022; PNAS 2018; iScience, 2019 & 2020; PNAS, 2016). His research group has been particularly interested in emulating a host-microbiome ecosystem that orchestrates human health and diseases by integrating transdisciplinary approaches of clinical microbiology, microfluidics, and tissue engineering. He has spearheaded to develop a “Patient’s Avatar” model by integrating patient-derived organoids, fecal microbiota, and tissue-specific immune cells to emulate the pathophysiology of inflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC) and colorectal cancer (CRC).
ACADEMIC & PROFESSIONAL APPOINTMENT
07/2022 – present Cleveland Clinic, Lerner Research Institute, Cleveland, OH, USA
Assistant Staff, Department of Inflammation and Immunity
02/2023 – present Assistant Staff, Department of Biomedical Engineering (Joint Appointment)
04/2023 – present Assistant Professor, Department of Biomedical Engineering, Cleveland Clinic Lerner College of Medicine (CCLCM) of Case Western Reserve University
01/2015 – 06/2022 The University of Texas at Austin, Austin, TX, USA
Assistant Professor, Department of Biomedical Engineering, Cockrell School of Engineering
EDUCATION & TRAINING
Harvard University, Boston, MA, USA
09/2012 – 12/2014 Technology Development Fellow, Wyss Institute for Biologically Inspired Engineering (Advisor: Donald E. Ingber, MD, PhD)
07/2009 – 08/2012 Postdoctoral Fellow, Wyss Institute for Biologically Inspired Engineering (Advisor: Donald E. Ingber, MD, PhD)
The University of Chicago, Chicago, IL, USA
03/2007 – 06/2009 Postdoctoral Scholar, Department of Chemistry (Advisor: Rustem F. Ismagilov, PhD)
Yonsei University, Seoul, Republic of Korea
09/2005 – 02/2007 Research Associate, Institute of Life Science and Biotechnology (Advisor: Chul Soo Shin, PhD)
09/2000 – 08/2005 PhD in Biotechnology (Advisor: Chul Soo Shin, PhD)
03/1998 – 08/2000 MS in Biotechnology (Advisor: Chul Soo Shin, PhD)
03/1994 – 02/1998 BE in Biotechnology
AWARDS & HONORS (Selected)
2023 Senior Research Award, Crohn’s and Colitis Foundation of America, USA
2023 2022 Inventor, Office of Innovations, Cleveland Clinic Foundation, USA
2023 CTSC Core Utilization Pilot Grant Award, Case Western Reserve University, USA
2022 Career Development Program Award, Lerner Research Institute, Cleveland Clinic, USA
2021 2020 Research Excellence in Korean Biomedical Science, Medical Research Information Center, Korea
2018 Technology Impact Award, Cancer Research Institute (CRI), USA
2017 Texas 4000 Seed Grant Award, Dept. of Biomedical Engineering, UT Austin, USA
2016 Innovator Awards, Kenneth Rainin Foundation, USA
2015 Featured Designer for Organs-on-Chips, Museum of Modern Art (MoMA), New York, USA
2013 Abcam Discovery 15 Contest Finalist ($1,000 credit), USA
2013 2013 Invented Here! Honoree. New England’s Breakthrough Inventions and Inventors. Boston, MA, USA
2013 Best Paper Award. ALine, Inc., 2013 ASME (NEMB 2013). Feb 4-6, 2013, Boston, MA, USA
2012 - 2014 Wyss Technology Development Fellowship, Wyss Institute, Harvard University, USA
2012 Best Presentation Award for Postdocs. The Korean Toxicologists Association in America. SOT 2012, San Francisco, CA, USA
2012 Postdoctoral Award (1st place). In Vitro and Alternative Methods Special Section, SOT 2012, San Francisco, CA, USA
2007 - 2008 Leo Kadanoff and Stuart Rice Postdoctoral Fellowship, The University of Chicago, USA
2003 - 2004 Fellowship for Young Scientist, Korea Research Foundation, Korea
2001 Scholarship for Excellent Student, Yonsei University, Seoul, Korea
1994 Yonsei Special Award for the Freshman in Matriculation, Yonsei University, Seoul, Korea
The Biomimetic MicroEngineering (BioME) laboratory has focused on innovating bioinspired engineering principles to uncover the fundamental mechanism in human health and diseases. The human Organ-on-a-Chip, also known as the Microphysiological System (MPS), has emerged as an alternative experimental model to accurately recapitulate the host-microbiome ecosystem and predict human physiological responses. We have created novel biomimicry to reconstitute the three-dimensional (3D) physical structure, physiological functions, and dynamic biomechanics of the living human gut.
We are particularly interested in emulating the host-microbiome interactions that orchestrate intestinal homeostasis and disease development. In collaboration with clinicians, our breakthrough technology enables us to develop unprecedented “Personalized Disease-on-a-Chip” models by integrating patient-derived organoids, microbiomes, and immune cells. Using this model, we have delved into the pathological contribution of the gut microbiome in gastrointestinal diseases such as inflammatory bowel disease (IBD) including Crohn’s disease (CD) and ulcerative colitis (UC), colorectal cancer (CRC), and infectious diseases.
Our overarching goal is to understand causality vs. consequence of the host-microbiome crosstalk at various disease milieus by leveraging a patient-specific Disease-on-a-Chip. We will continually innovate our disruptive technology to manipulate pathophysiological manifestation in the human oral cavity, nasal path, vagina, placenta, skin, liver, and gut-brain axis. Finally, we will disseminate our cutting-edge technology to contribute to scientific, clinical, and pharmaceutical communities by unraveling high-risk medical problems.
View publications for Hyun Jung Kim, PhD
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Selected Publications
Microbiome-mediated disease modeling in Organs-on-chips
We are seeking a talented, motivated candidate to join collaborative translational projects looking at the role of the gut microbiome in various human gastrointestinal (GI) diseases including inflammatory bowel disease (IBD) such as Crohn’s disease (CD), ulcerative colitis (UC), colorectal cancer (CRC), celiac disease (CeD), irritable bowel syndrome (IBS), or infectious diseases such as Clostridioides difficile infection (CDI). The multidisciplinary projects aim to discover the pathophysiological role of the gut microbiota on the initiation and development of GI diseases in concert with complex microenvironmental factors including epithelium, immune components, and mechanobiological stimulations.
Skills required: Rigorous scientific training in the design and analysis of research is necessary. A strong record of prior research accomplishments is encouraged. Successful postdoc candidates should present one or more of i) strong research expertise in mucosal immunology, cancer immunology, or host-microbiome interactions, ii) strong expertise in synthetic biology, metabolic engineering, or microbial genetic engineering, iii) strong skillsets in cell and tissue engineering, iv) strong disease-specific multi-omics training including single-cell transcriptomics and metabolomics, or v) strong academic records in human microphysiological system (MPS). Candidates should send their CV and a Cover Letter to Dr. Hyun Jung Kim ([email protected]). In the Cover Letter, please specify your qualifications pertinent to project requirements on the job description. It is highly recommended to include a 1-page research portfolio in your CV.
Development of a multiplex, scalable Organs-on-chips microplatform
The BioME lab at Lerner Research Institute at Cleveland Clinic is seeking a talented, motivated postdoctoral fellow to work on the development of a novel Organs-on-chips microplatform to be implementable for multiplex and scalable assessment of host-microbiome interactions. The successful postdoc candidates will work at Cleveland Clinic to innovate the structure and functionality of conventional Organ-on-a-chip devices for advanced modularity, interactive accessibility, and multi-functional affordability.
Skills required: Rigorous scientific training in the design and analysis of research is necessary. A strong record of prior research accomplishments is encouraged. The ideal candidates should have one or more of i) strong research expertise in mechanical engineering, manufacturing, automation, or mechatronics engineering, ii) strong technical experiences in human microphysiological system (MPS) or 3D printing/bioprinting, iii) strong skillsets in cell and tissue engineering, or iv) strong expertise in biomaterials and materials science. Candidates with track records in industry experiences in Organs-on-chips, device manufacturing, or high-throughput automated systems are highly encouraged to apply. Prospective candidates should send their CV and a Cover Letter to Dr. Hyun Jung Kim ([email protected]). In the Cover Letter, please specify your qualifications pertinent to project requirements on the job description. It is highly recommended to include a 1-page research portfolio in your CV.
Our education and training programs offer hands-on experience at one of the nationʼs top hospitals. Travel, publish in high impact journals and collaborate with investigators to solve real-world biomedical research questions.
Learn More